• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
322.4611705
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
18.62
96496.42
EPS(TTM)
Face Value()
Div & Yield %
62.12
1
0.69
 

Nihar Info Global Ltd - Financial Results For The Second Quarter And Half Year Ended 30Th September 2024.
Dec 05,2024
In response to the communication received from BSE via e-mail dated 4th December 2024 w.r.t the discrepancies in the Financials filed for the quarter and half year ended 30th September 2024 we are hereby enclosing the corrected copy of unaudited standalone and consolidated Financial Results for the Second Quarter and Half Year ended on 30th September 2024 as recommended by the Audit Committee of the Company accompanied by the Limited Review Report of the Auditors.